期刊文献+

中国流行株HIV-1B/C重组亚型包膜蛋白真核表达载体的构建及稳定表达细胞株的筛选 被引量:2

Construction of Eukaryotic Expression Vector and Screening of Cell Strain for Stable Expression of HIV-1 Subtype B/C Env
下载PDF
导出
摘要 目的获得高质量的中国流行株HIV-1B/C重组亚型包膜蛋白抗原。方法改造表达载体,以构建中国流行株HIV-1B/C重组亚型包膜蛋白基因带有筛选标记的真核细胞表达质粒,将所构建质粒转染真核细胞,用含有抗性的培养基筛选出能够高效、持续表达包膜蛋白的稳定表达细胞株。结果所构建的表达载体pVRPEnv转染细胞后可表达目的蛋白,并建立了稳定表达细胞系。结论获得了可以高效、持续稳定表达中国流行株HIV-1B/C重组亚型包膜蛋白的细胞株。 Objective To obtain the envelope protein(Env) of HIV-1 subtype B/C epidemic in China. Methods Insert puromycin gene into plnsmid pVR to construct a modified eukaryotic expression vector pVRP. Insert the Env gene of HIV-1 subtype B/C into the modified vector pVRP,then transfect 293T cells with the constructed recombinant plasmid pVRPEnv in the mediation of lipofectamine. Screen the cell strain for stable and high expression of Env with the medium containing puromycin. Identify the expressed protein by Western blot. Results Sequencing result proved that the eukaryotic expression vector pVR was successfully modified. Both restriction analysis and PCR amplification showed that an eukaryotic expression vector pVRPEnv was successfully constructed. Western blot proved the expression of gp160 in the screened positive cell clones integrated with Env gene. Conclusion A cell strain for high and stable expression of HIV-1 subtype B/C Env was obtained.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第4期365-367,共3页 Chinese Journal of Biologicals
基金 国家自然科学基金资助项目(30371317).
关键词 HIV-1 包膜蛋白 细胞系 HIV-1 Envelope protein Cell line
  • 相关文献

参考文献3

  • 1Wu YY,Hong KX,Agnès-Laurence C,et al.Molecular cloning and in vitro evaluation of an infectious simian-human immunodeficiency virus containing env of a primary Chinese HIV-1 subtype C isolate.J Med Primatol,2005,34(2):101-107.
  • 2Allan JS,Coligan JE,Barin F,et al.Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-Ⅲ.Science,1985,228:1091-1094.
  • 3Profy AT,Salinas PA,Eckler LI,et al.Epitopes recognized by the neutralizing antibodies of an HIV-Ⅰ infected individual.J Immunol,1990,144:4641-4647.

同被引文献14

  • 1Ferrantelli F, Rasmussen R.A, Hofmann-Lehmann R, et al. Do not underestimate the power of antibodies21essons from adoptive transfer of antibodies against HIV. Vaccine, 2002, 20 (Suppl 4A)6: 1-6.
  • 2Mascola JR, Louder MK, Winter C, et al. Human immunodeficiency vires type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J Virol, 2002, 76 (10): 4810-4821.
  • 3Simon V,Ho DD,Abdool Karim Q. HIV / AIDS epidemiology,pathogenesis,prevention,and treatment[J].{H}LANCET,2006,(9534):489-504.
  • 4McCoy LE,Weiss RA. Neutralizing antibodies to HIV-1 induced by immunization[J].{H}Journal of Experimental Medicine,2013,(2):209-223.
  • 5Leaman DP,Zwick MB. Increased functional stability and homogeneity of viral envelope spikes through directed evolution[J].{H}PLoS Pathogens,2013,(2):e1003184.
  • 6Burton DR,Desrosiers RC,Doms RW. HIV vaccine design and the neutralizing antibody problem[J].{H}Nature Immunology,2004,(3):233-236.
  • 7Chen X,Lu L,Qi Z. Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides[J].{H}Journal of Biological Chemistry,2010,(33):25506-25515.
  • 8Qi Z,Pan CG,Lu H. A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice[J].{H}Biochemical and Biophysical Research Communications,2010,(3):506-512.
  • 9Zhang MY,Wang Y,Mankowski MK. Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc:possible role of the prolonged half-life of the immunogen[J].{H}VACCINE,2009,(6):857-863.
  • 10Chen H,Xu X,Jones IM. Immunogenicity of the outer domain of a HIV-1 clade C gp120[J].{H}RETROVIROLOGY,2007,(1):33-41.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部